MediWound Ltd.

Healthcare

NASDAQ:MDWD · NASDAQ Global Market

Market Cap $154.68M Beta 0.15 P/E (TTM) -7.0

$14.24 -0.60%

-$0.09 today

52W Low $13.54High $21.26

Vol 0.07M · Avg 0.09M

EPS (TTM) -$2.03Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-25.01%

Period High

$21.09

Period Low

$13.73

Latest

$14.24

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

SELLAS Life Sciences Group, Inc.

NASDAQ:SLS

$1.18B

Genfit S.A.

GNFT

$445.68M

Cartesian Therapeutics, Inc.

NASDAQ:RNAC

$280.59M

Orchestra BioMed Holdings, Inc.

NASDAQ:OBIO

$233.98M

Eupraxia Pharmaceuticals Inc.

NASDAQ:EPRX

$212.93M

Inventiva S.A.

NASDAQ:IVA

$184.28M

Protara Therapeutics, Inc.

NASDAQ:TARA

$154.94M

Invivyd, Inc.

NASDAQ:IVVD

$128.63M

Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

$99.38M

Aardvark Therapeutics, Inc. Common Stock

NASDAQ:AARD

$85.74M

What is the latest MDWD filing?

The latest filing shown is 4 dated Jun 4, 2026.

How many recent filings does MDWD have?

Intrinsic Alpha currently shows 20 recent filings for MDWD.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.